Most non-English speakers in the US are turned away before their first cancer visit, according to new research

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research in the September 2023 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkreveals an ala

Updated on: February 18,2024

Most non-English speakers in the US are turned away before their first cancer visit, according to new research

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research in the September 2023 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkreveals an ala

Updated on:February 18,2024

Research shows potential new way to treat brain cancer

by Victoria University of WellingtonCredit: Victoria University of WellingtonResearch conducted at Victoria University of Wellington and the Malaghan Institute of Medical Research has suggested a

Updated on: May 31,2024

Research shows potential new way to treat brain cancer

by Victoria University of WellingtonCredit: Victoria University of WellingtonResearch conducted at Victoria University of Wellington and the Malaghan Institute of Medical Research has suggested a

Updated on:May 31,2024

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent

Updated on: January 16,2024

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent

Updated on:January 16,2024

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on: December 28,2023

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on:December 28,2023

Illuminating tumor cells with dark proteins

by Columbia UniversityRibosome roadblock effect: comparing the AMD1 tail sequence, poly(A) and the XBP1 stalling sequence. a–e, Reporter constructs shown on the left were transfected into HEK293T

Updated on: February 19,2024

Illuminating tumor cells with dark proteins

by Columbia UniversityRibosome roadblock effect: comparing the AMD1 tail sequence, poly(A) and the XBP1 stalling sequence. a–e, Reporter constructs shown on the left were transfected into HEK293T

Updated on:February 19,2024

Researchers identify innovative strategy with potential to enhance bowel cancer treatment

by University of GalwayGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112475Researchers at University of Galway studying cell interactions in bowel cancer h

Updated on: February 18,2024

Researchers identify innovative strategy with potential to enhance bowel cancer treatment

by University of GalwayGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112475Researchers at University of Galway studying cell interactions in bowel cancer h

Updated on:February 18,2024

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on: March 09,2024

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on:March 09,2024

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Updated on: March 01,2024

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Updated on:March 01,2024

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me

Updated on: April 01,2024

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me

Updated on:April 01,2024

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab

Updated on: January 30,2024

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab

Updated on:January 30,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on: January 30,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on:January 30,2024

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on: September 07,2024

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on:September 07,2024